Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Toxicol ; 35(6): 683-691, 2016 11.
Article in English | MEDLINE | ID: mdl-27733446

ABSTRACT

Morus alba L. (white mulberry) leaves are one of the oldest recognized traditional Chinese medicines. More recently, M alba leaves and their constituents, particularly iminosugars (or azasugars), have garnered attention for their ability to maintain normal blood glucose concentrations, an effect identified in both animal studies and human clinical trials. Reducose (Phynova Group Limited) is a commercial water-soluble extract of M alba leaves standardized to 5% 1-deoxynojirimycin (DNJ), an iminosugar with α-glucosidase inhibition properties. Although there is an extensive history of consumption of M alba leaves by humans and animals worldwide, suggesting that the leaves and their extracts have a relatively good safety profile, we are unaware of safety assessments on an extract containing a higher amount of DNJ than that occurs naturally. The current 28-day repeated dose oral toxicity study in rats, conducted according to Organisation for Economic Co-operation and Development guidelines, was carried out to assess the safety of Reducose. Male and female Hsd.Han Wistar rats (4 groups of 10 animals/sex) were administered Reducose via gavage at doses of 0, 1,000, 2,000 and 4,000 mg/kg body weight (bw)/d. No treatment-related mortality or adverse effects (per clinical observations, body weight/weight gain, food consumption, ophthalmoscopy, clinical pathology, gross pathology, organ weights, or histopathology) were observed, and no target organs were identified. The no observed adverse effect level was determined to be 4,000 mg/kg bw/d for both male and female rats, the highest dose tested.


Subject(s)
Morus , Plant Extracts/toxicity , Animals , Female , Male , No-Observed-Adverse-Effect Level , Plant Leaves , Rats , Toxicity Tests, Subacute
2.
Environ Toxicol Pharmacol ; 39(3): 1057-66, 2015 May.
Article in English | MEDLINE | ID: mdl-25863332

ABSTRACT

Subacute and subchronic toxicity of the herbicide Avalon(®), a mixture of bentazone and dicamba, were tested on rats. Avalon(®) was administered at dose levels of 250, 500 and 1000mg/kg body weight/day for 28 and 90 days. Alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) activities were monitored together with biochemistry parameters. The results showed that the mixture caused increases in the activities of ALT, AST and ALP, elevated concentrations of sodium, albumin and albumin/globulin ratio in males. In females, ALT activity, cholesterol and phosphate levels were increased. The changes generally were dose related and, in most cases, females exhibited lower susceptibility than males. The effects of a mixture are, in the most cases, different from the effects of the individual substances. The effects of bentazone were not prevalent which would be expected taking the composition of the mixture into account.


Subject(s)
Benzothiadiazines/toxicity , Dicamba/toxicity , Gene Expression Regulation, Enzymologic/drug effects , Herbicides/toxicity , Toxicity Tests, Subacute/methods , Toxicity Tests, Subchronic/methods , Alanine Transaminase/metabolism , Alkaline Phosphatase/metabolism , Animals , Aspartate Aminotransferases/metabolism , Benzothiadiazines/administration & dosage , Dicamba/administration & dosage , Dose-Response Relationship, Drug , Drug Combinations , Female , Herbicides/administration & dosage , Male , Rats , Sex Factors
3.
Int J Toxicol ; 30(4): 405-9, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21772023

ABSTRACT

L-(+)-ergothioneine has antioxidant and anti-inflammatory properties in vitro and in vivo and has uses as a dietary supplement and as an ingredient in foods, cosmetics, and as a pharmaceutical additive. The clastogenic potential and mutagenic of ergothioneine were assessed in vitro and in vivo. Ergothioneine concentrations up to 5000 µg/mL, with and without metabolic activation, was tested in the chromosome aberration assay with CHL cells and found not to induce structural chromosome aberrations. In the in vivo mammalian erythrocyte micronucleus test, ergothioneine was administered orally to male mice at doses up to 1500 mg/kg for potential genotoxic activity. No increase in the frequency of micronucleated polychromatic erythrocytes was observed.  Overall, ergothioneine was not genotoxic in these studies and provides additional experimental evidence supporting the safety of its use as a potential dietary supplement.


Subject(s)
DNA Damage/drug effects , Ergothioneine/toxicity , Mutagens/toxicity , Animals , Biotransformation , Cell Line , Chromatography, High Pressure Liquid , Chromatography, Liquid , Chromosome Aberrations/drug effects , Cricetinae , Dose-Response Relationship, Drug , Ergothioneine/chemistry , Erythrocytes/drug effects , Female , Lung/cytology , Male , Mass Spectrometry , Mice , Micronucleus Tests/methods , Mutagens/chemistry
4.
Toxicology ; 278(1): 39-45, 2010 Nov 28.
Article in English | MEDLINE | ID: mdl-20674647

ABSTRACT

The dietary antioxidant L-(+)-ergothioneine was tested for its potential mutagenic activity using the bacterial reverse mutation assay. The experiments were carried out using histidine-requiring auxotrophic strains of Salmonella typhimurium (Salmonella typhimurium TA98, TA100, TA1535 and TA1537), and the tryptophan-requiring auxotrophic strain of Escherichia coli (Escherichia coli WP2 uvrA) in the presence and absence of a post-mitochondrial supernatant (S9) prepared from livers of phenobarbital/ß-naphthoflavone-induced rats. The revertant colony numbers of vehicle control plates with and without S9 Mix were within the corresponding historical control data ranges. The reference mutagen treatments (positive controls) showed the expected, biologically relevant increases in induced revertant colonies in all experimental phases in all tester strains. No biologically relevant increases were observed in revertant colony numbers of any of the five test strains following treatment with L-(+)-ergothioneine at any concentration level, either in the presence or absence of metabolic activation (S9 Mix) in the performed experiments. On the basis of the data reported, it can be concluded that L-(+)-ergothioneine did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. Thus L-(+)-ergothioneine has no mutagenic activity on the applied bacteria tester strains under the test conditions used in this study. Research is continuing to define the role of L-(+)-ergothioneine in disease pathophysiology. Further studies on its safety are suggested.


Subject(s)
Antioxidants/toxicity , Ergothioneine/toxicity , Escherichia coli/drug effects , Salmonella typhimurium/drug effects , Escherichia coli/genetics , Humans , Mutagenicity Tests/methods , Salmonella typhimurium/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...